Clinical results of active surveillance for extra‐abdominal desmoid‐type fibromatosis
Abstract Background The treatment of choice for desmoid‐type fibromatosis (DF) has been changed to active surveillance (AS). However, few studies have reported clinical outcomes of AS modality in Asian countries. This study aimed to clarify the significance of AS as a DF treatment modality. Methods...
Main Authors: | Tomohisa Sakai, Yoshihiro Nishida, Kan Ito, Kunihiro Ikuta, Hiroshi Urakawa, Hiroshi Koike, Shiro Imagama |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-03-01
|
Series: | Cancer Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/cam4.5329 |
Similar Items
-
Immunohistochemical staining with non-phospho β-catenin as a diagnostic and prognostic tool of COX-2 inhibitor therapy for patients with extra-peritoneal desmoid-type fibromatosis
by: Tomohisa Sakai, et al.
Published: (2017-08-01) -
Activated Signaling Pathways and Targeted Therapies in Desmoid-Type Fibromatosis: A Literature Review
by: Milea J. M. Timbergen, et al.
Published: (2019-05-01) -
Less-invasive fascia-preserving surgery for abdominal wall desmoid
by: Yoshihiro Nishida, et al.
Published: (2021-09-01) -
Desmoid-Type Fibromatosis
by: Dorian Yarih Garcia-Ortega, et al.
Published: (2020-07-01) -
Development of multifocal extra‐abdominal desmoid fibromatosis after surgical resection
by: Brendon M. Bauer, et al.
Published: (2019-12-01)